15,974 Shares in Ardent Health Partners, LLC (NYSE:ARDT) Bought by Balyasny Asset Management L.P.

Balyasny Asset Management L.P. bought a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 15,974 shares of the company’s stock, valued at approximately $273,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. US Bancorp DE acquired a new position in Ardent Health Partners during the 4th quarter worth $31,000. R Squared Ltd acquired a new position in Ardent Health Partners during the 4th quarter worth $37,000. New York State Common Retirement Fund acquired a new position in Ardent Health Partners during the 4th quarter worth $48,000. JPMorgan Chase & Co. acquired a new position in Ardent Health Partners during the 3rd quarter worth $154,000. Finally, Wells Fargo & Company MN grew its stake in Ardent Health Partners by 52.6% during the 4th quarter. Wells Fargo & Company MN now owns 8,704 shares of the company’s stock worth $149,000 after purchasing an additional 3,002 shares in the last quarter.

Ardent Health Partners Stock Up 1.1%

Ardent Health Partners stock opened at $15.40 on Friday. Ardent Health Partners, LLC has a fifty-two week low of $11.31 and a fifty-two week high of $20.72. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The company has a market capitalization of $2.20 billion and a P/E ratio of 9.45. The stock has a 50-day simple moving average of $13.13 and a 200-day simple moving average of $14.83.

Ardent Health Partners (NYSE:ARDT) last posted its earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.08. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Equities research analysts expect that Ardent Health Partners, LLC will post 1.23 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on ARDT shares. Guggenheim boosted their target price on Ardent Health Partners from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, May 9th. Stephens reaffirmed an “overweight” rating and set a $22.00 price target on shares of Ardent Health Partners in a report on Tuesday, April 1st. Mizuho decreased their price target on Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating for the company in a report on Wednesday, April 9th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $21.00 price target on shares of Ardent Health Partners in a report on Thursday. Finally, Morgan Stanley decreased their price target on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Ardent Health Partners presently has an average rating of “Buy” and an average target price of $20.75.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.